Capecitabine in combination with oxaliplatin as first-line therapy for advanced gastric cancer: A case report

Rosario Mazzola; Massimiliano Alù; Vita Leonardi; Giuseppe Procopio; Biagio Agostara

doi:10.1700/611.7148

Capecitabine in combination with oxaliplatin as first-line therapy for advanced gastric cancer: A case report

Rosario Mazzola, Massimiliano Alù, Vita Leonardi, Giuseppe Procopio, Biagio Agostara

Fondazione IRCCS Istituto Nazionale dei Tumori

Research output: Contribution to journal › Article › peer-review

Abstract

Gastric cancer is one of the most common cancers worldwilde. The five-year survival for stage IV gastric cancer is around 5-10% in Western countries. Advanced gastric cancer is sensitive to numerous agents, but there is no generally accepted standard regimen. Here we report on a case of advanced gastric cancer occurring in a 72-yearold man who underwent treatment with capecitabine plus oxaliplatin, achieving a complete response. Free full text available at www.tumorionline.it.

Original language	English
Pages (from-to)	115-118
Number of pages	4
Journal	Tumori
Volume	97
Issue number	1
DOIs	https://doi.org/10.1700/611.7148
Publication status	Published - Jan 2011

Keywords

Case report
First-line therapy
Metastatic gastric cancer
XELOX

ASJC Scopus subject areas

Cancer Research
Oncology

Access to Document

10.1700/611.7148

Cite this

@article{9af335fb4d194a23b98882c4f5381c74,

title = "Capecitabine in combination with oxaliplatin as first-line therapy for advanced gastric cancer: A case report",

abstract = "Gastric cancer is one of the most common cancers worldwilde. The five-year survival for stage IV gastric cancer is around 5-10% in Western countries. Advanced gastric cancer is sensitive to numerous agents, but there is no generally accepted standard regimen. Here we report on a case of advanced gastric cancer occurring in a 72-yearold man who underwent treatment with capecitabine plus oxaliplatin, achieving a complete response. Free full text available at www.tumorionline.it.",

keywords = "Case report, First-line therapy, Metastatic gastric cancer, XELOX",

author = "Rosario Mazzola and Massimiliano Al{\`u} and Vita Leonardi and Giuseppe Procopio and Biagio Agostara",

year = "2011",

month = jan,

doi = "10.1700/611.7148",

language = "English",

volume = "97",

pages = "115--118",

journal = "Tumori",

issn = "0300-8916",

publisher = "SAGE Publications Ltd",

number = "1",

}

TY - JOUR

T1 - Capecitabine in combination with oxaliplatin as first-line therapy for advanced gastric cancer

T2 - A case report

AU - Mazzola, Rosario

AU - Alù, Massimiliano

AU - Leonardi, Vita

AU - Procopio, Giuseppe

AU - Agostara, Biagio

PY - 2011/1

Y1 - 2011/1

N2 - Gastric cancer is one of the most common cancers worldwilde. The five-year survival for stage IV gastric cancer is around 5-10% in Western countries. Advanced gastric cancer is sensitive to numerous agents, but there is no generally accepted standard regimen. Here we report on a case of advanced gastric cancer occurring in a 72-yearold man who underwent treatment with capecitabine plus oxaliplatin, achieving a complete response. Free full text available at www.tumorionline.it.

AB - Gastric cancer is one of the most common cancers worldwilde. The five-year survival for stage IV gastric cancer is around 5-10% in Western countries. Advanced gastric cancer is sensitive to numerous agents, but there is no generally accepted standard regimen. Here we report on a case of advanced gastric cancer occurring in a 72-yearold man who underwent treatment with capecitabine plus oxaliplatin, achieving a complete response. Free full text available at www.tumorionline.it.

KW - Case report

KW - First-line therapy

KW - Metastatic gastric cancer

KW - XELOX

UR - http://www.scopus.com/inward/record.url?scp=79953851867&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953851867&partnerID=8YFLogxK

U2 - 10.1700/611.7148

DO - 10.1700/611.7148

M3 - Article

C2 - 21528674

AN - SCOPUS:79953851867

SN - 0300-8916

VL - 97

SP - 115

EP - 118

JO - Tumori

JF - Tumori

IS - 1

ER -

Capecitabine in combination with oxaliplatin as first-line therapy for advanced gastric cancer: A case report

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this